Published in J Transl Med on September 27, 2014
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol (2015) 0.97
Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer. Onco Targets Ther (2016) 0.78
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells. Cell Rep (2017) 0.76
The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. J Cancer (2016) 0.75
The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition. Int J Mol Sci (2017) 0.75
Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma. Sci Rep (2017) 0.75
Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma. Oncol Lett (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18
Epidemiology of primary liver cancer. Semin Liver Dis (1999) 4.48
Galectins. Structure and function of a large family of animal lectins. J Biol Chem (1994) 4.29
Hepatocellular carcinoma: the need for progress. J Clin Oncol (2005) 3.11
Extracellular functions of galectin-3. Glycoconj J (2004) 2.15
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer (2003) 2.09
On the role of galectin-3 in cancer apoptosis. Apoptosis (2005) 1.60
Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res (2001) 1.55
The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res (1999) 1.51
LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Cancer Cell (2007) 1.47
Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer (1999) 1.46
Tumor-associated galectin-3 modulates the function of tumor-reactive T cells. Cancer Res (2008) 1.26
Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol (2010) 1.14
Contributions of galectin-3 and -9 to epithelial cell adhesion analyzed by single cell force spectroscopy. J Biol Chem (2007) 1.10
Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1). PLoS One (2011) 1.08
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res (2006) 1.00
Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-catenin. Acta Pharmacol Sin (2012) 0.99
Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium. Clin Cancer Res (2013) 0.97
Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells. J Biol Chem (2012) 0.96
Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies. Am J Pathol (2006) 0.96
Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice. Glycobiology (2008) 0.95
Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus. Glycoconj J (2004) 0.94
Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas. Clin Cancer Res (2002) 0.93
Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma. Hepatol Res (2008) 0.93
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia. Blood (2013) 0.92
Identification of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain. Cancer Invest (2008) 0.91
Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer. Anticancer Res (2006) 0.91
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. J Mol Med (Berl) (2012) 0.90
Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin. Cancer Res (2012) 0.90
Epigenetic regulation of galectin-3 expression by β1 integrins promotes cell adhesion and migration. J Biol Chem (2012) 0.89
Galectin-3 expression in colorectal cancer: relation to invasion and metastasis. Anticancer Res (2007) 0.89
Claudin-1 as a promoter of EMT in hepatocellular carcinoma. Oncogene (2013) 0.88
Galectin-3 regulates p21 stability in human prostate cancer cells. Oncogene (2012) 0.83
CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions. J Thorac Oncol (2012) 0.81
Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma. PLoS One (2013) 0.81
Tumor targeting and SPECT imaging properties of an (111)In-labeled galectin-3 binding peptide in prostate carcinoma. Nucl Med Biol (2009) 0.79
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J (2010) 5.04
Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol (2012) 3.68
Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet (2002) 2.00
Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study. Ann Surg Oncol (2010) 2.00
GJB2 mutation spectrum in 2,063 Chinese patients with nonsyndromic hearing impairment. J Transl Med (2009) 1.66
Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol (2013) 1.63
Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. Cardiovasc Ther (2010) 1.55
A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial. EuroIntervention (2013) 1.53
Angiographic and clinical comparisons of intravascular ultrasound- versus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions: two-year results from a randomised AIR-CTO study. EuroIntervention (2015) 1.53
Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry. Circ J (2014) 1.52
Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1,503 patients. Ann Surg Oncol (2010) 1.51
Correlation of red cell distribution width with the severity of coronary artery disease: a large Chinese cohort study from a single center. Chin Med J (Engl) (2013) 1.49
Sugar promotes vegetative phase change in Arabidopsis thaliana by repressing the expression of MIR156A and MIR156C. Elife (2013) 1.44
Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol (2007) 1.44
Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results. Chin Med J (Engl) (2010) 1.40
Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry. Chin Med J (Engl) (2009) 1.39
Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer (2012) 1.38
Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program. Catheter Cardiovasc Interv (2015) 1.37
Health related quality of life measured by SF-36: a population-based study in Shanghai, China. BMC Public Health (2008) 1.36
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine. Cancer Immunol Immunother (2007) 1.29
Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice. Stem Cells (2012) 1.26
Time-dependent photoluminescence blue shift of the quantum dots in living cells: effect of oxidation by singlet oxygen. J Am Chem Soc (2006) 1.25
Synthesis and insecticidal activities of novel anthranilic diamides containing modified N-pyridylpyrazoles. J Agric Food Chem (2010) 1.25
Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology (2012) 1.24
Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults. PLoS One (2008) 1.24
Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol (2012) 1.22
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol (2009) 1.22
Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas. J Immunother (2008) 1.22
Emerging risk of H7N9 influenza in China. Lancet (2013) 1.21
Community health needs assessment with precede-proceed model: a mixed methods study. BMC Health Serv Res (2009) 1.20
Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA. PLoS One (2012) 1.20
Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors. World J Gastroenterol (2007) 1.19
The relationship between self-rated health and objective health status: a population-based study. BMC Public Health (2013) 1.18
Percutaneous coronary intervention with anomalous origin of right coronary artery: case reports and literature review. J Geriatr Cardiol (2013) 1.18
Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B. World J Gastroenterol (2005) 1.17
Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes (2010) 1.16
A retrospective survey of research design and statistical analyses in selected Chinese medical journals in 1998 and 2008. PLoS One (2010) 1.15
Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J (2008) 1.15
The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS One (2011) 1.15
Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer. PLoS One (2012) 1.12
Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients. Int J Biol Sci (2011) 1.10
Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood (2002) 1.09
MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer (2010) 1.09
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol (2008) 1.08
Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology (2011) 1.08
The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients. Ann Surg Oncol (2013) 1.07
Inflammatory response is associated with aortic dissection. Ageing Res Rev (2008) 1.07
V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett (2004) 1.07
The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One (2012) 1.06
Misuse of statistical methods in 10 leading Chinese medical journals in 1998 and 2008. ScientificWorldJournal (2011) 1.06
High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients. World J Gastroenterol (2010) 1.06
Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration. World J Cardiol (2010) 1.05
Clinical utility of a microbubble-enhancing contrast ("SonoVue") in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study. Eur J Radiol (2012) 1.04
Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes. JACC Cardiovasc Interv (2010) 1.04
Transcatheter occlusion of the ruptured sinus of Valsalva aneurysm with an Amplatzer duct occluder. Int J Cardiol (2007) 1.04
Increased red cell distribution width in patients with slow coronary flow syndrome. Clinics (Sao Paulo) (2013) 1.03
Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene. Mol Cancer (2010) 1.03
Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity. Cardiovasc Diabetol (2012) 1.03
Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology. BMC Gastroenterol (2009) 1.03
Conversion of fatty aldehydes into alk (a/e)nes by in vitro reconstituted cyanobacterial aldehyde-deformylating oxygenase with the cognate electron transfer system. Biotechnol Biofuels (2013) 1.02
Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev (2012) 1.01
Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma. Surgery (2010) 1.01
A computerized system for signal detection in spontaneous reporting system of Shanghai China. Pharmacoepidemiol Drug Saf (2009) 1.01
IL-17A promotes immune cell recruitment in human esophageal cancers and the infiltrating dendritic cells represent a positive prognostic marker for patient survival. J Immunother (2013) 1.00
Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-α and matrix metalloproteinase-9 in aortic dissection. Clin Chim Acta (2011) 1.00
Reduced expression of transcription factor AP-2α is associated with gastric adenocarcinoma prognosis. PLoS One (2011) 1.00
A computerized system for detecting signals due to drug-drug interactions in spontaneous reporting systems. Br J Clin Pharmacol (2010) 1.00
Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy. Chin J Cancer (2010) 1.00
Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma. Int J Cancer (2011) 0.99
Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China. Am J Gastroenterol (2010) 0.99
Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients. J Biol Chem (2012) 0.98
Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett (2007) 0.98
Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo. EuroIntervention (2013) 0.98